Struthers Richard Scott — SEC insider filings
SEC reporting owner CIK 1746298. 34 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2020-12-04 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 5,000 shares, $65,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 21 legs across 12 filings — 691,718 shares, $22,664,829 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 84.
- Largest priced transaction: sale of 199,082 shares @ $30.56 ($6,083,946) in Crinetics Pharmaceuticals, Inc., filed 2023-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO, Director | 33 | 2 legs · 5,000 sh · $65,000 | 21 legs · 691,718 sh · $22,664,829 | 84 |
| Frazier Life Sciences Acquisition Corp. II (FLSC) | Director | 1 | — | — | — |
Insider filings — Struthers Richard Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 3 | Frazier Life Sciences Acquisition Corp. II (FLSC) | Holdings only — no transactions reported | EDGAR |
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 248,043 @ $85 · Disposition to issuer (D): 1,000 @ $85 · Disposition to issuer (D): 136,805 @ $85 · Disposition to issuer (D): 106,000 @ $85 · Disposition to issuer (D): 110,000 @ $85 · Disposition to issuer (D): 100,000 @ $85 · +14 more | EDGAR |
| 2026-08-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 3,969 @ $25.19 · Option exercise (M): 4,422 @ $22.61 · Option exercise (M): 6,542 @ $15.29 · Option exercise (M): 4,995 @ $20.02 · Option exercise (M): 3,969 (derivative) @ $0 · Option exercise (M): 4,422 (derivative) @ $0 · +2 more | EDGAR |
| 2026-06-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 222,200 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 80,000 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 222,200 @ $0 · Gift (G): 80,000 @ $0 · +8 more | EDGAR |
| 2026-03-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 13,196 @ $37.11 · Sale (S): 8,785 @ $37.77 | EDGAR |
| 2026-02-25 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 62,000 @ $0 · Grant/award (A): 228,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 16,342 @ $9.28 · Option exercise (M): 28,400 @ $15.29 · Option exercise (M): 16,342 (derivative) @ $0 · Option exercise (M): 28,400 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 4,000 @ $45 | EDGAR |
| 2025-05-16 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 90,400 @ $0 · Gift (G): 90,400 @ $0 | EDGAR |
| 2025-04-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 81,270 @ $1.91 · Option exercise (M): 81,270 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 16,463 @ $34.17 · Sale (S): 875 @ $34.83 | EDGAR |
| 2025-02-24 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 89,000 @ $0 · Grant/award (A): 313,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 10,000 @ $57.57 | EDGAR |
| 2024-05-10 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 107,448 @ $9.28 · Sale (S): 107,448 @ $49.40 · Option exercise (M): 107,448 (derivative) @ $0 | EDGAR |
| 2024-04-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 350 @ $0 | EDGAR |
| 2024-04-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 20,000 @ $1.91 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 40,951 @ $9.28 · Sale (S): 40,951 @ $49.17 · Option exercise (M): 40,951 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 12,687 @ $38.14 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Gift (G): 60,000 @ $0 · Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0 | EDGAR |
| 2023-11-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 50,000 @ $1.91 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2023-11-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 918 @ $9.28 · Sale (S): 918 @ $29.95 · Option exercise (M): 199,082 @ $9.28 · Sale (S): 199,082 @ $30.56 · Option exercise (M): 918 (derivative) @ $0 · Option exercise (M): 199,082 (derivative) @ $0 | EDGAR |
| 2023-08-16 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 10,000 @ $1.91 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2023-07-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 24,384 @ $20.14 · Sale (S): 11,459 @ $20.17 · Sale (S): 14,157 @ $20.35 | EDGAR |
| 2023-06-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 50,000 @ $20.81 | EDGAR |
| 2023-03-17 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 4,628 @ $17.12 | EDGAR |
| 2023-03-03 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 61,650 @ $0 · Grant/award (A): 287,700 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 11,100 @ $1.91 · Option exercise (M): 11,100 (derivative) @ $0 | EDGAR |
| 2022-04-15 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 24,674 @ $25.42 · Sale (S): 44,793 @ $26.52 · Sale (S): 69,176 @ $27.53 | EDGAR |
| 2022-04-07 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 21,357 @ $25.34 | EDGAR |
| 2022-03-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 53,400 @ $0 · Grant/award (A): 249,200 (derivative) @ $0 | EDGAR |
| 2021-09-09 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 10,000 @ $25 · Sale (S): 10,000 @ $25 · Sale (S): 10,000 @ $25 | EDGAR |
| 2021-03-02 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 294,000 (derivative) @ $0 | EDGAR |
| 2020-12-04 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Purchase (P): 1,000 @ $12.60 · Purchase (P): 4,000 @ $13.10 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1746298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs